Hamad Medical partners globally to boost healthcare innovation
Hamad Medical Corporation signed a memorandum of understanding with Boehringer Ingelheim to promote innovation in healthcare and support clinical research in Qatar. The collaboration aims to develop research capabilities and improve patient outcomes by increasing the attraction of international clinical trials and developing advanced infrastructure for evaluating health technologies. This partnership seeks to empower researchers to access the latest treatments and technologies, and to foster medical innovation in line with Qatar’s healthcare system vision.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)